123 related articles for article (PubMed ID: 20616454)
1. [The effect of YGS (Yi-Gan-San) on BPSD and care burden of dementia].
Machida A; Yamada Y; Kimura S; Kozaki K; Toba K
Nihon Ronen Igakkai Zasshi; 2010; 47(3):262-3. PubMed ID: 20616454
[No Abstract] [Full Text] [Related]
2. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients.
Iwasaki K; Satoh-Nakagawa T; Maruyama M; Monma Y; Nemoto M; Tomita N; Tanji H; Fujiwara H; Seki T; Fujii M; Arai H; Sasaki H
J Clin Psychiatry; 2005 Feb; 66(2):248-52. PubMed ID: 15705012
[TBL] [Abstract][Full Text] [Related]
3. Effect of Yi-Gan San on psychiatric symptoms and sleep structure at patients with behavioral and psychological symptoms of dementia.
Shinno H; Inami Y; Inagaki T; Nakamura Y; Horiguchi J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):881-5. PubMed ID: 18243460
[TBL] [Abstract][Full Text] [Related]
4. Traditional uses, chemical compounds, pharmacological activities and clinical studies on the traditional Chinese prescription Yi-Gan San.
Yang SY; Lin ZX; Xian YF; Zhang HM; Xu HX
J Ethnopharmacol; 2023 Feb; 302(Pt A):115859. PubMed ID: 36280017
[TBL] [Abstract][Full Text] [Related]
5. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of Yi-Gan San against beta amyloid-induced cytotoxicity on rat cortical neurons.
Tateno M; Ukai W; Ono T; Saito S; Hashimoto E; Saito T
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1704-7. PubMed ID: 18675875
[TBL] [Abstract][Full Text] [Related]
7. Yi-gan san for the treatment of borderline personality disorder: an open-label study.
Miyaoka T; Furuya M; Yasuda H; Hayashia M; Inagaki T; Horiguchi J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):150-4. PubMed ID: 17765378
[TBL] [Abstract][Full Text] [Related]
8. Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study.
Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
Clin Neuropharmacol; 2009; 32(1):6-9. PubMed ID: 19471183
[TBL] [Abstract][Full Text] [Related]
9. Chinese herbal medicine Yi-Gan-San decreases the lipid accumulation in mouse 3T3-L1 adipocytes by modulating the activities of transcription factors SREBP-1c and FoxO1.
Izumi M; Seki T; Iwasaki K; Sakamoto K
Tohoku J Exp Med; 2009 Sep; 219(1):53-62. PubMed ID: 19713685
[TBL] [Abstract][Full Text] [Related]
10. [Clinical usage of Yi-gan san-schizophrenia, borderline personality disorder, dyskinesia etc-].
Horiguchi J
Seishin Shinkeigaku Zasshi; 2012; 114(6):708-18. PubMed ID: 23094294
[TBL] [Abstract][Full Text] [Related]
11. Yi-gan san for treatment of charles bonnet syndrome (visual hallucination due to vision loss): an open-label study.
Miyaoka T; Furuya M; Kristian L; Wake R; Kawakami K; Nagahama M; Kawano K; Ieda M; Tsuchie K; Horiguchi J
Clin Neuropharmacol; 2011; 34(1):24-7. PubMed ID: 21164340
[TBL] [Abstract][Full Text] [Related]
12. Yokukansan in the Treatment of Behavioral and Psychological Symptoms of Dementia: An Updated Meta-Analysis of Randomized Controlled Trials.
Matsunaga S; Kishi T; Iwata N
J Alzheimers Dis; 2016 Sep; 54(2):635-43. PubMed ID: 27497482
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of an herbal medicine, Yi-Gan San on MPP+/MPTP-induced cytotoxicity in vitro and in vivo.
Doo AR; Kim SN; Park JY; Cho KH; Hong J; Eun-Kyung K; Moon SK; Jung WS; Lee H; Jung JH; Park HJ
J Ethnopharmacol; 2010 Sep; 131(2):433-42. PubMed ID: 20633628
[TBL] [Abstract][Full Text] [Related]
14. [Aging in brain and mind--drug therapy for patients with behavioral and psychological symptoms of dementia(BPSD)].
Inanaga K
Seishin Shinkeigaku Zasshi; 2007; 109(7):703-8. PubMed ID: 17969960
[No Abstract] [Full Text] [Related]
15. The associations between behavioral-psychological symptoms of dementia (BPSD) and coping strategy, burden of care and personality style among low-income caregivers of patients with dementia.
Baharudin AD; Din NC; Subramaniam P; Razali R
BMC Public Health; 2019 Jun; 19(Suppl 4):447. PubMed ID: 31196141
[TBL] [Abstract][Full Text] [Related]
16. Yokukansan inhibits social isolation-induced aggression and methamphetamine-induced hyperlocomotion in rodents.
Uchida N; Egashira N; Iwasaki K; Ishibashi A; Tashiro R; Nogami A; Manome N; Abe M; Takasaki K; Mishima K; Takata J; Oishi R; Nishimura R; Fujiwara M
Biol Pharm Bull; 2009 Mar; 32(3):372-5. PubMed ID: 19252280
[TBL] [Abstract][Full Text] [Related]
17. Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies.
Iwasaki K; Maruyama M; Tomita N; Furukawa K; Nemoto M; Fujiwara H; Seki T; Fujii M; Kodama M; Arai H
J Clin Psychiatry; 2005 Dec; 66(12):1612-3. PubMed ID: 16401166
[No Abstract] [Full Text] [Related]
18. Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortex.
Egashira N; Iwasaki K; Ishibashi A; Hayakawa K; Okuno R; Abe M; Uchida N; Mishima K; Takasaki K; Nishimura R; Oishi R; Fujiwara M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1516-20. PubMed ID: 18558456
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment with Yokukansan for behavioral and psychological symptoms of Parkinsonian dementia.
Kawanabe T; Yoritaka A; Shimura H; Oizumi H; Tanaka S; Hattori N
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):284-7. PubMed ID: 19948198
[TBL] [Abstract][Full Text] [Related]
20. Caregiving burden and gain among adult-child caregivers caring for parents with dementia in China: the partial mediating role of reciprocal filial piety.
Yu H; Wu L; Chen S; Wu Q; Yang Y; Edwards H
Int Psychogeriatr; 2016 Nov; 28(11):1845-1855. PubMed ID: 27255608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
